The Role of Creatine in the Management of Amyotrophic Lateral Sclerosis and Other Neurodegenerative Disorders (original) (raw)

• Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001; 344(22): 1688–700
  PubMed CAS Google Scholar
• Cluskey S, Ramsden DB. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. Mol Pathol 2001; 54(6): 386–92
  PubMed CAS Google Scholar
• Rosen DR. Mutations in Cu/Zn superoxide dismutase are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59–62
  PubMed CAS Google Scholar
• Ferrante RJ, Shinobu LA, Schulz JB, et al. Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation. Ann Neurol 1997; 42(3): 326–34
  PubMed CAS Google Scholar
• Andersen P, Morita M, Brown R. Genetics of amyotrophic lateral sclerosis: an overview. In: Brown R, Meininger V, Swash M, editors. Amyotrophic lateral sclerosis. London: Martin-Dunitz, 2000
  Google Scholar
• Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992; 59(5): 1609–23
  PubMed CAS Google Scholar
• Halliwell B. Oxygen radicals as key mediators in neurological disease: fact or fiction? Ann Neurol 1992; 32 Suppl.: S10–15
  PubMed CAS Google Scholar
• Beckman JS, Estevez AG, Crow JP, et al. Superoxide dismutase and the death of motoneurons in ALS. Trends Neurosci 2001; 24(11 Suppl.): S15–20
  PubMed CAS Google Scholar
• Brown RH. Superoxide dismutase and familial amyotrophic lateral sclerosis: new insights into mechanisms and treatments. Ann Neurol 1996; 39(2): 145–6
  PubMed Google Scholar
• Menzies FM, Cookson MR, Taylor RW, et al. Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. Brain 2002; 125 (Pt 7): 1522–33
  PubMed Google Scholar
• Menzies FM, Ince PG, Shaw PJ. Mitochondrial involvement in amyotrophic lateral sclerosis. Neurochem Int 2002; 40(6): 543–51
  PubMed CAS Google Scholar
• Jung C, Higgins CM, Xu Z. Mitochondrial electron transport chain complex dysfunction in a transgenic mouse model for amyotrophic lateral sclerosis. J Neurochem 2002; 83(3): 535–45
  PubMed CAS Google Scholar
• Kaal EC, Vlug AS, Versleijen MW, et al. Chronic mitochondrial inhibition induces selective motoneuron death in vitro: a new model for amyotrophic lateral sclerosis. J Neurochem 2000; 74(3): 1158–65
  PubMed CAS Google Scholar
• Bowling AC, Schulz JB, Brown RH, et al. Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993; 61(6): 2322–5
  PubMed CAS Google Scholar
• Beal MF. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 1992; 31(2): 119–30
  PubMed CAS Google Scholar
• Fosslien E. Mitochondrial medicine: molecular pathology of defective oxidative phosphorylation. Ann Clin Lab Sci 2001; 31(1): 25–67
  PubMed CAS Google Scholar
• Martin LJ. Neuronal death in amyotrophic lateral sclerosis is apoptosis: possible contribution of a programmed cell death mechanism. J Neuropathol Exp Neurol 1999; 58(5): 459–71
  PubMed CAS Google Scholar
• Rothstein JD, Kuncl R, Chaudhry V, et al. Excitatory amino acids in amyotrophic lateral sclerosis: an update. Ann Neurol 1991; 30(2): 224–5
  PubMed CAS Google Scholar
• Rothstein JD. Therapeutic horizons for amyotrophic lateral sclerosis. Curr Opin Neurobiol 1996; 6(5): 679–87
  PubMed CAS Google Scholar
• Kruman II, Pedersen WA, Springer JE, et al. ALS-linked Cu/ Zn-SOD mutation increases vulnerability of motor neurons to excitotoxicity by a mechanism involving increased oxidative stress and perturbed calcium homeostasis. Exp Neurol 1999; 160(1): 28–39
  PubMed CAS Google Scholar
• Carri MT, Ferri A, Battistoni A, et al. Expression of a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis induces mitochondrial alteration and increase of cytosolic Ca2+ concentration in transfected neuroblastoma SH-SY5Y cells. FEBS Lett 1997; 414(2): 365–8
  PubMed CAS Google Scholar
• Canton T, Pratt J, Stutzmann JM, et al. Glutamate uptake is decreased tardively in the spinal cord of FALS mice. Neuroreport 1998; 9(5): 775–8
  PubMed CAS Google Scholar
• Trotti D, Rolfs A, Danbolt NC, et al. SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter [published erratum appears in Nat Neurosci 1999 Sep; 2(9): 848]. Nat Neurosci 1999; 2(5): 427–33
  PubMed CAS Google Scholar
• Howland DS, Liu J, She Y, et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc Natl Acad Sci U S A 2002; 99(3): 1604–9
  PubMed CAS Google Scholar
• Meldrum BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 2000; 130(4S Suppl.): 1007–1015S
  Google Scholar
• Schulz JB, Lindenau J, Seyfried J, et al. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 2000; 267(16): 4904–11
  PubMed CAS Google Scholar
• Campiani G, Fattorusso C, De Angelis M, et al. Neuronal high-affinity sodium-dependent glutamate transporters (EAATs): targets for the development of novel therapeutics against neurodegenerative diseases. Curr Pharm Des 2003; 9(8): 599–625
  PubMed CAS Google Scholar
• Pearson AM, Young RB. Diseases and disorders of muscle. Adv Food Nutr Res 1993; 37: 339–423
  PubMed CAS Google Scholar
• Persky AM, Brazeau GA. Clinical pharmacology of the dietary supplement creatine monohydrate. Pharmacol Rev 2001; 53(2): 161–76
  PubMed CAS Google Scholar
• Jacobs I. Dietary creatine monohydrate supplementation. Can J Appl Physiol 1999; 24(6): 503–14
  PubMed CAS Google Scholar
• Greenhaff PL. Creatine and its application as an ergogenic aid. Int J Sport Nutr 1995; 5 Suppl.: S100–110
  PubMed Google Scholar
• Greenhaff PL, Bodin K, Soderlund K, et al. Effect of oral creatine supplementation on skeletal muscle phosphocreatine resynthesis. Am J Physiol 1994; 266 (5 Pt 1): E725–730
  PubMed CAS Google Scholar
• Bogdanis GC, Nevill ME, Boobis LH, et al. Contribution of phosphocreatine and aerobic metabolism to energy supply during repeated sprint exercise. J Appl Physiol 1996; 80(3): 876–84
  PubMed CAS Google Scholar
• Benzi G, Ceci A. Creatine as nutritional supplementation and medicinal product. J Sports Med Phys Fitness 2001; 41(1): 1–10
  PubMed CAS Google Scholar
• Guerrero-Ontiveros ML, Wallimann T. Creatine supplementation in health and disease: effects of chronic creatine ingestion in vivo: down-regulation of the expression of creatine transporter isoforms in skeletal muscle. Mol Cell Biochem 1998; 184(1–2): 427–37
  PubMed CAS Google Scholar
• Febbraio MA, Flanagan TR, Snow RJ, et al. Effect of creatine supplementation on intramuscular TCr, metabolism and performance during intermittent, supramaximal exercise in humans. Acta Physiol Scand 1995; 155(4): 387–95
  PubMed CAS Google Scholar
• Hultman E, Soderlund K, Timmons JA, et al. Muscle creatine loading in men. J Appl Physiol 1996; 81(1): 232–7
  PubMed CAS Google Scholar
• Tarnopolsky MA, MacLennan DP. Creatine monohydrate supplementation enhances high-intensity exercise performance in males and females. Int J Sport Nutr Exerc Metab 2000; 10(4): 452–63
  PubMed CAS Google Scholar
• Harris RC, Soderlund K, Hultman E. Elevation of creatine in resting and exercised muscle of normal subjects by creatine supplementation. Clin Sci 1992; 83(3): 367–74
  PubMed CAS Google Scholar
• Casey A, Greenhaff PL. Does dietary creatine supplementation play a role in skeletal muscle metabolism and performance? Am J Clin Nutr 2000; 72(2 Suppl.): 607–617S
  Google Scholar
• Tarnopolsky MA. Potential benefits of creatine monohydrate supplementation in the elderly. Curr Opin Clin Nutr Metab Care 2000; 3(6): 497–502
  PubMed CAS Google Scholar
• Terjung RL, Clarkson P, Eichner ER, et al. American College of Sports Medicine roundtable. The physiological and health effects of oral creatine supplementation. Med Sci Sports Exerc 2000; 32(3): 706–17
  CAS Google Scholar
• Tarnopolsky MA, Roy BD, MacDonald JR. A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies. Muscle Nerve 1997; 20(12): 1502–9
  PubMed CAS Google Scholar
• Pulido SM, Passaquin AC, Leijendekker WJ, et al. Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells. FEBS Lett 1998; 439(3): 357–62
  PubMed CAS Google Scholar
• Felber S, Skladal D, Wyss M, et al. Oral creatine supplementation in Duchenne muscular dystrophy: a clinical and 31P magnetic resonance spectroscopy study. Neurol Res 2000; 22(2): 145–50
  PubMed CAS Google Scholar
• Harris RC, Nevill M, Harris DB, et al. Absorption of creatine supplied as a drink, in meat or in solid form. J Sports Sci 2002; 20(2): 147–51
  PubMed Google Scholar
• Haugland RB, Chang DT. Insulin effect on creatine transport in skelatal muscle (38464). Proc Soc Exp Biol Med 1975; 148(1): 1–4
  PubMed CAS Google Scholar
• Koszalka TR, Andrew CL, Brent RL. Effect of insulin on the uptake of creatine-1-14 C by skeletal muscle in normal and x-irradiated rats. Proc Soc Exp Biol Med 1972; 139(4): 1265–71
  PubMed CAS Google Scholar
• Steenge GR, Lambourne J, Casey A, et al. Stimulatory effect of insulin on creatine accumulation in human skeletal muscle. Am J Physiol 1998; 275 (6 Pt 1): E974–979
  PubMed CAS Google Scholar
• Steenge GR, Simpson EJ, Greenhaff PL. Protein- and carbohydrate-induced augmentation of whole body creatine retention in humans. J Appl Physiol 2000; 89(3): 1165–71
  PubMed CAS Google Scholar
• Green AL, Hultman E, Macdonald IA, et al. Carbohydrate ingestion augments skeletal muscle creatine accumulation during creatine supplementation in humans. Am J Physiol 1996; 271 (5 Pt 1): E821–826
  PubMed CAS Google Scholar
• Vandenberghe K, Gillis N, Van Leemputte M, et al. Caffeine counteracts the ergogenic action of muscle creatine loading. J Appl Physiol 1996; 80(2): 452–7
  PubMed CAS Google Scholar
• Doherty M, Smith PM, Davison RC, et al. Caffeine is ergogenic after supplementation of oral creatine monohydrate. Med Sci Sports Exerc 2002; 34(11): 1785–92
  PubMed CAS Google Scholar
• Kreider RB, Ferreira M, Wilson M, et al. Effects of creatine supplementation on body composition, strength, and sprint performance. Med Sci Sports Exerc 1998; 30(1): 73–82
  PubMed CAS Google Scholar
• Vandenberghe K, Goris M, Van Hecke P, et al. Long-term creatine intake is beneficial to muscle performance during resistance training. J Appl Physiol 1997; 83(6): 2055–63
  PubMed CAS Google Scholar
• Birch R, Noble D, Greenhaff PL. The influence of dietary creatine supplementation on performance during repeated bouts of maximal isokinetic cycling in man. Eur J Appl Physiol Occup Physiol 1994; 69(3): 268–76
  PubMed CAS Google Scholar
• Bosco C, Tihanyi J, Pucspk J, et al. Effect of oral creatine supplementation on jumping and running performance. Int J Sports Med 1997; 18(5): 369–72
  PubMed CAS Google Scholar
• Dawson B, Cutler M, Moody A, et al. Effects of oral creatine loading on single and repeated maximal short sprints. Aust J Sci Med Sport 1995; 27(3): 56–61
  PubMed CAS Google Scholar
• Engelhardt M, Neumann G, Berbalk A, et al. Creatine supplementation in endurance sports. Med Sci Sports Exerc 1998; 30(7): 1123–9
  PubMed CAS Google Scholar
• Grindstaff PD, Kreider R, Bishop R, et al. Effects of creatine supplementation on repetitive sprint performance and body composition in competitive swimmers. Int J Sport Nutr 1997; 7(4): 330–46
  PubMed CAS Google Scholar
• Maganaris CN, Maughan RJ. Creatine supplementation enhances maximum voluntary isometric force and endurance capacity in resistance trained men. Acta Physiol Scand 1998; 163(3): 279–87
  PubMed CAS Google Scholar
• McNaughton LR, Dalton B, Tarr J. The effects of creatine supplementation on high-intensity exercise performance in elite performers. Eur J Appl Physiol Occup Physiol 1998; 78(3): 236–40
  PubMed CAS Google Scholar
• Prevost MC, Nelson AG, Morris GS. Creatine supplementation enhances intermittent work performance. Res Q Exerc Sport 1997; 68(3): 233–40
  PubMed CAS Google Scholar
• Schneider DA, McDonough PJ, Fadel PJ, et al. Creatine supplementation and the total work performed during 15-s and 1-min bouts of maximal cycling. Aust J Sci Med Sport 1997; 29(3): 65–8
  PubMed CAS Google Scholar
• Smith JC, Stephens DP, Hall EL, et al. Effect of oral creatine ingestion on parameters of the work rate-time relationship and time to exhaustion in high-intensity cycling. Eur J Appl Physiol Occup Physiol 1998; 77(4): 360–5
  PubMed CAS Google Scholar
• Casey A, Constantin-Teodosiu D, Howell S, et al. Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans. Am J Physiol 1996; 271 (1 Pt 1): E31–37
  PubMed CAS Google Scholar
• Earnest CP, Snell PG, Rodriguez R, et al. The effect of creatine monohydrate ingestion on anaerobic power indices, muscular strength and body composition. Acta Physiol Scand 1995; 153(2): 207–9
  PubMed Google Scholar
• Juhn MS, Tarnopolsky M. Oral creatine supplementation and athletic performance: a critical review [published erratum appears in Clin J Sport Med 1999 Apr; 9 (2): 62]. Clin J Sport Med 1998; 8(4): 286–97
  PubMed CAS Google Scholar
• Van Schuylenbergh R, Van Leemputte M, Hespel P. Effects of oral creatine-pyruvate supplementation in cycling performance. Int J Sports Med 2003; 24(2): 144–50
  PubMed Google Scholar
• Snow RJ, Turnbull J, da Silva S, et al. Creatine supplementation and riluzole treatment provide similar beneficial effects in copper, zinc superoxide dismutase (G93A) transgenic mice. Neuroscience 2003; 119(3): 661–7
  PubMed CAS Google Scholar
• Odland LM, MacDougall JD, Tarnopolsky MA, et al. Effect of oral creatine supplementation on muscle [PCr] and short-term maximum power output. Med Sci Sports Exerc 1997; 29(2): 216–9
  PubMed CAS Google Scholar
• Barnett C, Hinds M, Jenkins DG. Effects of oral creatine supplementation on multiple sprint cycle performance. Aust J Sci Med Sport 1996; 28(1): 35–9
  PubMed CAS Google Scholar
• Preen D, Dawson B, Goodman C, et al. Pre-exercise oral creatine ingestion does not improve prolonged intermittent sprint exercise in humans. J Sports Med Phys Fitness 2002; 42(3): 320–9
  PubMed CAS Google Scholar
• Lemon PW. Dietary creatine supplementation and exercise performance: why inconsistent results? Can J Appl Physiol 2002; 27(6): 663–81
  PubMed CAS Google Scholar
• Wyss M, Wallimann T. Creatine metabolism and the consequences of creatine depletion in muscle. Mol Cell Biochem 1994; 133-134: 51–66
  Google Scholar
• Brannon TA, Adams GR, Conniff CL, et al. Effects of creatine loading and training on running performance and biochemical properties of rat skeletal muscle. Med Sci Sports Exerc 1997; 29(4): 489–95
  PubMed CAS Google Scholar
• Balsom PD, Harridge SD, Soderlund K, et al. Creatine supplementation per se does not enhance endurance exercise performance. Acta Physiol Scand 1993; 149(4): 521–3
  PubMed CAS Google Scholar
• Bemben MG, Bemben DA, Loftiss DD, et al. Creatine supplementation during resistance training in college football athletes. Med Sci Sports Exerc 2001; 33(10): 1667–73
  PubMed CAS Google Scholar
• Clarkson PM, Rawson ES. Nutritional supplements to increase muscle mass. Crit Rev Food Sci Nutr 1999; 39(4): 317–28
  PubMed CAS Google Scholar
• Klivenyi P, Ferrante RJ, Matthews RT, et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med 1999; 5(3): 347–50
  PubMed CAS Google Scholar
• Dolder M, Wendt S, Wallimann T. Mitochondrial creatine kinase in contact sites: interaction with porin and adenine nucleotide translocase, role in permeability transition and sensitivity to oxidative damage. Biol Signals Recept 2001; 10(1–2): 93–111
  PubMed CAS Google Scholar
• WallimannT, Wyss M, Brdiczka D, et al. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphocreatine circuit’ for cellular energy homeostasis. Biochem J 1992; 281 (Pt 1): 21–40
  Google Scholar
• Fontaine E, Bernardi P. Progress on the mitochondrial permeability transition pore: regulation by complex I and ubiquinone analogs. J Bioenerg Biomembr 1999; 31(4): 335–45
  PubMed CAS Google Scholar
• Tarnopolsky MA, Beal MF. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders. Ann Neurol 2001; 49(5): 561–74
  PubMed CAS Google Scholar
• Ferrante RJ, Andreassen OA, Jenkins BG, et al. Neuroprotective effects of creatine in a transgenic mouse model of Huntington’s disease. J Neurosci 2000; 20(12): 4389–97
  PubMed CAS Google Scholar
• Steeghs K, Benders A, Oerlemans F, et al. Altered Ca2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies. Cell 1997; 89(1): 93–103
  PubMed CAS Google Scholar
• de Groof AJ, Fransen JA, Errington RJ, et al. The creatine kinase system is essential for optimal refill of the sarcoplasmic reticulum Ca2+ store in skeletal muscle. J Biol Chem 2002; 277(7): 5275–84
  PubMed Google Scholar
• Andreassen OA, Jenkins BG, Dedeoglu A, et al. Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation. J Neurochem 2001; 77(2): 383–90
  PubMed CAS Google Scholar
• Xu CJ, Klunk WE, Kanfer JN, et al. Phosphocreatine-dependent glutamate uptake by synaptic vesicles: a comparison with atp-dependent glutamate uptake. J Biol Chem 1996; 271(23): 13435–40
  PubMed CAS Google Scholar
• Brewer GJ, Wallimann TW. Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons. J Neurochem 2000; 74(5): 1968–78
  PubMed CAS Google Scholar
• Lawler JM, Barnes WS, Wu G, et al. Direct antioxidant properties of creatine. Biochem Biophys Res Commun 2002; 290(1): 47–52
  PubMed CAS Google Scholar
• Derave W, Van Den Bosch L, Lemmens G, et al. Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment. Neurobiol Dis 2003 Aug; 13(3): 264–72
  PubMed CAS Google Scholar
• Matthews RT, Yang L, Jenkins BG, et al. Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington’s disease. J Neurosci 1998; 18(1): 156–63
  PubMed CAS Google Scholar
• Zhang W, Narayanan M, Friedlander RM. Additive neuroprotective effects of minocycline with creatine in a mouse model of ALS. Ann Neurol 2003; 53(2): 267–70
  PubMed CAS Google Scholar
• Klivenyi P, Kiaei M, Gardian G, et al. Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. J Neurochem 2004; 88(3): 576–82
  PubMed CAS Google Scholar
• Shefner J, Cudkowicz M, Shchoenfeld D, et al. A clinical trial of creatine in patients with amyotrophic lateral sclerosis. Abstracts from the 14th International Symposium on ALS/MND. Amyotroph Lateral Scler Other Motor Neuron Disord 2003; 4Suppl. 1: 28–9
  Google Scholar
• Groeneveld GJ, Veldink JH, van der Tweel I, et al. A randomized sequential trial of creatine in amyotrophic lateral sclerosis. Ann Neurol 2003; 53(4): 437–45
  PubMed CAS Google Scholar
• Drory VE, Gross D. No effect of creatine on respiratory distress in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2002; 3(1): 43–6
  PubMed CAS Google Scholar
• Mazzini L, Balzarini C, Colombo R, et al. Effects of creatine supplementation on exercise performance and muscular strength in amyotrophic lateral sclerosis: preliminary results. J Neurol Sci 2001; 191(1–2): 139–44
  PubMed CAS Google Scholar
• Rosenfeld J, Jackson C, Smith J, et al. A pilot trial of ultrapure creatine in amyotrophic lateral sclerosis [abstract]. Amyotroph Lateral Scler Other Motor Neuron Disord 2001; 2Suppl 2 (1466-0822): 20
  Google Scholar
• Matthews RT, Ferrante RJ, Klivenyi P, et al. Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp Neurol 1999; 157(1): 142–9
  PubMed CAS Google Scholar
• Shear DA, Haik KL, Dunbar GL. Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats. Neuroreport 2000; 11(9): 1833–7
  PubMed CAS Google Scholar
• Dedeoglu A, Kubilus JK, Yang L, et al. Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington’s disease transgenic mice. J Neurochem 2003; 85(6): 1359–67
  PubMed CAS Google Scholar
• Walter MC, Reilich P, Lochmuller H, et al. Creatine monohydrate in myotonic dystrophy: a double-blind, placebo-controlled clinical study. J Neurol 2002; 249(12): 1717–22
  PubMed CAS Google Scholar
• Doherty TJ, Lougheed K, Markez J, et al. Creatine monohydrate does not increase strength in patients with hereditary neuropathy. Neurology 2001; 57(3): 559–60
  PubMed CAS Google Scholar
• Tarnopolsky M, Martin J. Creatine monohydrate increases strength in patients with neuromuscular disease. Neurology 1999; 52(4): 854–7
  PubMed CAS Google Scholar
• Passaquin AC, Renard M, Kay L, et al. Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice. Neuromuscul Disord 2002; 12(2): 174–82
  PubMed Google Scholar
• Walter MC, Lochmuller H, Reilich P, et al. Creatine monohydrate in muscular dystrophies: a double-blind, placebo-controlled clinical study. Neurology 2000; 54(9): 1848–50
  PubMed CAS Google Scholar
• Louis M, Lebacq J, Poortmans JR, et al. Beneficial effects of creatine supplementation in dystrophic patients. Muscle Nerve 2003; 27(5): 604–10
  PubMed CAS Google Scholar
• Juhn MS, Tarnopolsky M. Potential side effects of oral creatine supplementation: a critical review [published erratum appears in Clin J Sport Med 1999 Apr; 9 (2): 62]. Clin J Sport Med 1998; 8(4): 298–304
  PubMed CAS Google Scholar
• Schilling BK, Stone MH, Utter A, et al. Creatine supplementation and health variables: a retrospective study. Med Sci Sports Exerc 2001; 33(2): 183–8
  PubMed CAS Google Scholar
• Tarnopolsky MA, Parise G, Yardley NJ, et al. Creatine-dextrose and protein-dextrose induce similar strength gains during training. Med Sci Sports Exerc 2001; 33(12): 2044–52
  PubMed CAS Google Scholar
• Ingwall JS, Morales MF, Stockdale FE. Creatine and the control of myosin synthesis in differentiating skeletal muscle. Proc Natl Acad Sci U S A 1972; 69(8): 2250–3
  PubMed CAS Google Scholar
• Ingwall JS, Weiner CD, Morales MF, et al. Specificity of creatine in the control of muscle protein synthesis. J Cell Biol 1974; 62(1): 145–51
  PubMed CAS Google Scholar
• Ingwall JS, Morales MF, Stockdale FE, et al. Creatine: a possible stimulus skeletal cardiac muscle hypertrophy. Recent Adv Stud Cardiac Struct Metab 1975; 8: 467–81
  PubMed CAS Google Scholar
• Ingwall JS. Creatine and the control of muscle-specific protein synthesis in cardiac and skeletal muscle. Circ Res 1976; 38(5 Suppl. 1): I115–123
  Google Scholar
• Parise G, Mihic S, MacLennan D, et al. Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis. J Appl Physiol 2001; 91(3): 1041–7
  PubMed CAS Google Scholar
• Vierck JL, Icenoggle DL, Bucci L, et al. The effects of ergogenic compounds on myogenic satellite cells. Med Sci Sports Exerc 2003; 35(5): 769–76
  PubMed CAS Google Scholar
• Dangott B, Schultz E, Mozdziak PE. Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy. Int J Sports Med 2000; 21(1): 13–6
  PubMed CAS Google Scholar
• Wyss M, Felber S, Skladal D, et al. The therapeutic potential of oral creatine supplementation in muscle disease. Med Hypotheses 1998; 51(4): 333–6
  PubMed CAS Google Scholar
• Tarnopolsky M, Parise G, Fu MH, et al. Acute and moderateterm creatine monohydrate supplementation does not affect creatine transporter mRNA or protein content in either young or elderly humans. Mol Cell Biochem 2003; 244(1–2): 159–66
  PubMed CAS Google Scholar
• Mihic S, MacDonald JR, McKenzie S, et al. Acute creatine loading increases fat-free mass, but does not affect blood pressure, plasma creatinine, or CK activity in men and women. Med Sci Sports Exerc 2000; 32(2): 291–6
  PubMed CAS Google Scholar